Silencing CDCA8 could suppresses tumor growth, proliferation, and stemness of HCC by inactivating AKT/β–Catenin Signaling, and regulating the CDK1/cyclin B1 signaling axis (42–45). Here, CDCA8 is linked to neoplasm.